KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (ONC) Assets Average (2016 - 2025)

BeOne Medicines (ONC) has disclosed Assets Average for 9 consecutive years, with $5.2 billion as the latest value for Q1 2024.

  • On a quarterly basis, Assets Average fell 2.63% to $5.2 billion in Q1 2024 year-over-year; TTM through Mar 2024 was $5.2 billion, a 2.63% decrease, with the full-year FY2024 number at $5.4 billion, up 4.27% from a year prior.
  • Assets Average was $5.2 billion for Q1 2024 at BeOne Medicines, up from $5.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $7.1 billion in Q3 2022 to a low of $3.1 billion in Q1 2020.
  • A 5-year average of $5.4 billion and a median of $5.4 billion in 2021 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 219.67% in 2020, then decreased 22.1% in 2023.
  • BeOne Medicines' Assets Average stood at $5.6 billion in 2020, then increased by 23.77% to $6.9 billion in 2021, then dropped by 11.68% to $6.1 billion in 2022, then decreased by 17.24% to $5.1 billion in 2023, then grew by 3.77% to $5.2 billion in 2024.
  • Per Business Quant, the three most recent readings for ONC's Assets Average are $5.2 billion (Q1 2024), $5.1 billion (Q4 2023), and $5.5 billion (Q3 2023).